Search research articles
Contact Us
Filters
Showing results (291-300 of 341) with videos related to
Page
of 35
Sort By:
NPJ Breast Cancer
|
September 5, 2019
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer
Swati Gupta, Veronique Neumeister, John McGuire, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
September 27, 2014
Conducting nanofibers and organogels derived from the self-assembly of tetrathiafulvalene-appended dipeptides
Siva Krishna Mohan Nalluri, Nadezhda Shivarova, Alexander L Kanibolotsky, et al.
Plos One
|
March 3, 2016
Paenibacillus lentimorbus Inoculation Enhances Tobacco Growth and Extenuates the Virulence of Cucumber mosaic virus
Susheel Kumar, Puneet Singh Chauhan, Lalit Agrawal, et al.
Nature Communications
|
December 1, 2019
An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
Balazs Acs, Fahad Shabbir Ahmed, Swati Gupta, et al.
Clinical Pharmacology and Therapeutics
|
July 2, 2023
Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR-T and TCR-T Cell Therapies: An Industry Perspective
Hardik Mody, Ken Ogasawara, Xu Zhu, et al.
BMC Infectious Diseases
|
April 19, 2015
Prevalence and correlates of HPV among women attending family-planning clinics in Thailand
Morgan A Marks, Swati Gupta, Kai-Li Liaw, et al.
Journal for Immunotherapy of Cancer
|
September 20, 2019
Closed system RT-qPCR as a potential companion diagnostic test for immunotherapy outcome in metastatic melanoma
Swati Gupta, Leena McCann, Yvonne G Y Chan, et al.
Regulatory Toxicology and Pharmacology : RTP
|
March 22, 2017
Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics
Christina L Zuch de Zafra, Vito G Sasseville, Steven Matsumoto, et al.
Regulatory Toxicology and Pharmacology : RTP
|
April 23, 2017
Corrigendum to "Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics" [Regul. Toxicol. Pharmacol. (2017) 221-230]
Christina L Zuch de Zafra, Vito G Sasseville, Steven Matsumoto, et al.
Zygote (Cambridge, England)
|
June 9, 2017
Impact of oocyte-secreted factors on its developmental competence in buffalo
Swati Gupta, Sriti Pandey, Mehtab S Parmar, et al.
Page
of 35
Search research articles
Search
Showing results (291-300 of 341) with videos related to
Sort By:
Page
of 35
NPJ Breast Cancer
|
September 5, 2019
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer
Swati Gupta, Veronique Neumeister, John McGuire, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
September 27, 2014
Conducting nanofibers and organogels derived from the self-assembly of tetrathiafulvalene-appended dipeptides
Siva Krishna Mohan Nalluri, Nadezhda Shivarova, Alexander L Kanibolotsky, et al.
Plos One
|
March 3, 2016
Paenibacillus lentimorbus Inoculation Enhances Tobacco Growth and Extenuates the Virulence of Cucumber mosaic virus
Susheel Kumar, Puneet Singh Chauhan, Lalit Agrawal, et al.
Nature Communications
|
December 1, 2019
An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
Balazs Acs, Fahad Shabbir Ahmed, Swati Gupta, et al.
Clinical Pharmacology and Therapeutics
|
July 2, 2023
Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR-T and TCR-T Cell Therapies: An Industry Perspective
Hardik Mody, Ken Ogasawara, Xu Zhu, et al.
BMC Infectious Diseases
|
April 19, 2015
Prevalence and correlates of HPV among women attending family-planning clinics in Thailand
Morgan A Marks, Swati Gupta, Kai-Li Liaw, et al.
Journal for Immunotherapy of Cancer
|
September 20, 2019
Closed system RT-qPCR as a potential companion diagnostic test for immunotherapy outcome in metastatic melanoma
Swati Gupta, Leena McCann, Yvonne G Y Chan, et al.
Regulatory Toxicology and Pharmacology : RTP
|
March 22, 2017
Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics
Christina L Zuch de Zafra, Vito G Sasseville, Steven Matsumoto, et al.
Regulatory Toxicology and Pharmacology : RTP
|
April 23, 2017
Corrigendum to "Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics" [Regul. Toxicol. Pharmacol. (2017) 221-230]
Christina L Zuch de Zafra, Vito G Sasseville, Steven Matsumoto, et al.
Zygote (Cambridge, England)
|
June 9, 2017
Impact of oocyte-secreted factors on its developmental competence in buffalo
Swati Gupta, Sriti Pandey, Mehtab S Parmar, et al.
Page
of 35